Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial(Nature Medicine, 10.1038/s41591-023-02758-x)

Yara L. Verschoor; Joris van de Haar; José G. van den Berg; Johanna W. van Sandick; Liudmila L. Kodach; Jolanda M. van Dieren; Sara Balduzzi; Cecile Grootscholten; Marieke E. IJsselsteijn; Alexander A. F. A. Veenhof; Koen J. Hartemink; Marieke A. Vollebergh; Adham Jurdi; Shruti Sharma; Erik Spickard; Emilia C. Owers; Annemarieke Bartels-Rutten; Peggy den Hartog; Noel F. C. C. de Miranda; Monique E. van Leerdam; John B. A. G. Haanen; Ton N. Schumacher; Emile E. Voest; Myriam Chalabi

doi:10.1038/s41591-024-02898-8

Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial(Nature Medicine, 10.1038/s41591-023-02758-x)

Yara L. Verschoor, Joris van de Haar, José G. van den Berg, Johanna W. van Sandick, Liudmila L. Kodach, Jolanda M. van Dieren, Sara Balduzzi, Cecile Grootscholten, Marieke E. IJsselsteijn, Alexander A. F. A. Veenhof, Koen J. Hartemink, Marieke A. Vollebergh, Adham Jurdi, Shruti Sharma, Erik Spickard, Emilia C. Owers, Annemarieke Bartels-Rutten, Peggy den Hartog, Noel F. C. C. de Miranda, Monique E. van LeerdamJohn B. A. G. Haanen, Ton N. Schumacher, Emile E. Voest, Myriam Chalabi

Research output: Contribution to journal › Comment/Letter to the editor › Academic

1 Citation (Scopus)

Abstract

In the version of the article initially published, the Data Availability section and Reporting Summary contained the wrong accession code for the data deposited in the European Genome-Phenome Archive. This has now been updated to “EGAS50000000168” in the HTML and PDF versions of the article.

Original language	English
Journal	Nature medicine
Early online date	2024
DOIs	https://doi.org/10.1038/s41591-024-02898-8
Publication status	E-pub ahead of print - 2024

Access to Document

10.1038/s41591-024-02898-8

Cite this

Verschoor, Y. L., van de Haar, J., van den Berg, J. G., van Sandick, J. W., Kodach, L. L., van Dieren, J. M., Balduzzi, S., Grootscholten, C., IJsselsteijn, M. E., Veenhof, A. A. F. A., Hartemink, K. J., Vollebergh, M. A., Jurdi, A., Sharma, S., Spickard, E., Owers, E. C., Bartels-Rutten, A., den Hartog, P., de Miranda, N. F. C. C., ... Chalabi, M. (2024). Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial(Nature Medicine, 10.1038/s41591-023-02758-x). Nature medicine. Advance online publication. https://doi.org/10.1038/s41591-024-02898-8

@article{9043b71b46a041ba8683bbbe81acedea,

title = "Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial(Nature Medicine, 10.1038/s41591-023-02758-x)",

abstract = "In the version of the article initially published, the Data Availability section and Reporting Summary contained the wrong accession code for the data deposited in the European Genome-Phenome Archive. This has now been updated to “EGAS50000000168” in the HTML and PDF versions of the article.",

author = "Verschoor, {Yara L.} and {van de Haar}, Joris and {van den Berg}, {Jos{\'e} G.} and {van Sandick}, {Johanna W.} and Kodach, {Liudmila L.} and {van Dieren}, {Jolanda M.} and Sara Balduzzi and Cecile Grootscholten and IJsselsteijn, {Marieke E.} and Veenhof, {Alexander A. F. A.} and Hartemink, {Koen J.} and Vollebergh, {Marieke A.} and Adham Jurdi and Shruti Sharma and Erik Spickard and Owers, {Emilia C.} and Annemarieke Bartels-Rutten and {den Hartog}, Peggy and {de Miranda}, {Noel F. C. C.} and {van Leerdam}, {Monique E.} and Haanen, {John B. A. G.} and Schumacher, {Ton N.} and Voest, {Emile E.} and Myriam Chalabi",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

doi = "10.1038/s41591-024-02898-8",

language = "English",

journal = "Nature medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

}

Verschoor, YL, van de Haar, J, van den Berg, JG, van Sandick, JW, Kodach, LL, van Dieren, JM, Balduzzi, S, Grootscholten, C, IJsselsteijn, ME, Veenhof, AAFA, Hartemink, KJ, Vollebergh, MA, Jurdi, A, Sharma, S, Spickard, E, Owers, EC, Bartels-Rutten, A, den Hartog, P, de Miranda, NFCC, van Leerdam, ME, Haanen, JBAG, Schumacher, TN, Voest, EE & Chalabi, M 2024, 'Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial(Nature Medicine, 10.1038/s41591-023-02758-x)', Nature medicine. https://doi.org/10.1038/s41591-024-02898-8

Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial(Nature Medicine, 10.1038/s41591-023-02758-x). / Verschoor, Yara L.; van de Haar, Joris; van den Berg, José G. et al.
In: Nature medicine, 2024.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Author Correction

T2 - Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial(Nature Medicine, 10.1038/s41591-023-02758-x)

AU - Verschoor, Yara L.

AU - van de Haar, Joris

AU - van den Berg, José G.

AU - van Sandick, Johanna W.

AU - Kodach, Liudmila L.

AU - van Dieren, Jolanda M.

AU - Balduzzi, Sara

AU - Grootscholten, Cecile

AU - IJsselsteijn, Marieke E.

AU - Veenhof, Alexander A. F. A.

AU - Hartemink, Koen J.

AU - Vollebergh, Marieke A.

AU - Jurdi, Adham

AU - Sharma, Shruti

AU - Spickard, Erik

AU - Owers, Emilia C.

AU - Bartels-Rutten, Annemarieke

AU - den Hartog, Peggy

AU - de Miranda, Noel F. C. C.

AU - van Leerdam, Monique E.

AU - Haanen, John B. A. G.

AU - Schumacher, Ton N.

AU - Voest, Emile E.

AU - Chalabi, Myriam

PY - 2024

Y1 - 2024

N2 - In the version of the article initially published, the Data Availability section and Reporting Summary contained the wrong accession code for the data deposited in the European Genome-Phenome Archive. This has now been updated to “EGAS50000000168” in the HTML and PDF versions of the article.

AB - In the version of the article initially published, the Data Availability section and Reporting Summary contained the wrong accession code for the data deposited in the European Genome-Phenome Archive. This has now been updated to “EGAS50000000168” in the HTML and PDF versions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85186925951&partnerID=8YFLogxK

U2 - 10.1038/s41591-024-02898-8

DO - 10.1038/s41591-024-02898-8

M3 - Comment/Letter to the editor

C2 - 38448792

SN - 1078-8956

JO - Nature medicine

JF - Nature medicine

ER -

Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial(Nature Medicine, 10.1038/s41591-023-02758-x)

Abstract

Access to Document

Other files and links

Cite this